Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation |
| |
Authors: | Su Man Lee Jae Yong Park Dong Sun Kim |
| |
Institution: | 260. Department of Anatomy, Kyungpook National University, Daegu, 702-422, Korea 160. Internal Medicine, School of Medicine, Kyungpook National University, Daegu, 702-422, Korea
|
| |
Abstract: | Lung cancer is a leading cause of cancer-related mortality across the world and tobacco smoking is the major risk factor. The Wnt signaling pathway is known to be involved in smoke-induced tumorigenesis in the lung. Promoter hypermethylation of Wnt inhibitory factor 1 (Wif1) has become a common event in a number of human tumors. Using a methylation-specific PCR, hypermethylation of the Wif1 gene promoter was evaluated in 139 primary nonsmall cell lung cancers (NSCLCs) and its correlation with clinicopathological and prognostic parameters was evaluated. Methylation of Wif1 was observed in 47.5% and 20.9% of neoplastic and adjacent normal lung tissues, respectively. Its methylation rate tended to be higher in stage I than stages II-IIIA. Results of Kaplan-Meier analysis showed no significant difference in overall survival according to Wif1 methylation status. However, Wif1 methylation showed an association with unfavorable prognosis of adenocarcinoma (AC) patients with EGFR mutation. According to our current findings, Wif1 promoter methylation is an early, frequent event as an epigenetic field manner and could be considered as a useful prognostic marker for AC patients with EGFR mutation. Further investigation into the therapeutic potential of this finding is warranted. |
| |
Keywords: | EGFR hypermethylation MSP NSCLC prognosis Wif1 |
本文献已被 SpringerLink 等数据库收录! |
|